The Overlooked Drivers of Drug Development: Analytical Rigor, Stability, and Scalable FormulationJun 12, 2026 10:51:40 AM
Lipid Nanoparticles and RNA Therapeutics: Solving the Delivery Challenge at the Heart of Gene TherapyJun 9, 2026 10:55:48 AM
Designing Aseptic Manufacturing for Ophthalmic Nanosuspensions: Why Facility Infrastructure MattersJun 1, 2026 11:17:28 AM
Speed Is No Longer a Competitive Advantage within Drug Development - It’s a RequirementMay 29, 2026 10:30:13 PM
Ascendia Pharmaceutical Solutions Puts Customers First During Formulation Development & ManufacturingMay 18, 2026 2:50:25 PM
Scale-Up from Development to GMP for Lipid Nanoparticles and Nanosuspensions: Why CDMO Experience Really MattersMay 8, 2026 2:09:29 PM
Ascendia Pharmaceutical Solutions Founder and CEO Named EY Entrepreneur Of The Year® 2026 New Jersey FinalistApr 24, 2026 6:14:51 PM
Long-Acting Injectable HIV Therapies: Advanced Formulation Strategies for Improved Adherence and Combination Drug DeliveryApr 21, 2026 1:09:25 PM
Ascendia Pharmaceutical Solutions at INTERPHEX 2026: Connecting Innovation, Equipment, and Science in New YorkApr 15, 2026 1:52:37 PM
Ascendia Pharmaceutical Solutions to Exhibit at CPhI Americas 2026 in PhiladelphiaMar 31, 2026 1:56:39 PM
.jpg)
